Suppr超能文献

浸润于爱泼斯坦-巴尔病毒相关胃癌中的抗原特异性CD8(+)细胞毒性T淋巴细胞频率增加。

Increased frequency of antigen-specific CD8(+) cytotoxic T lymphocytes infiltrating an Epstein-Barr virus-associated gastric carcinoma.

作者信息

Kuzushima K, Nakamura S, Nakamura T, Yamamura Y, Yokoyama N, Fujita M, Kiyono T, Tsurumi T

机构信息

Laboratory of Viral Oncology, Aichi Cancer Center Research Institute, Nagoya 464-0021, Japan.

出版信息

J Clin Invest. 1999 Jul;104(2):163-71. doi: 10.1172/JCI6062.

Abstract

Gastric adenocarcinomas carrying Epstein-Barr virus (EBV) are known to be accompanied by massive lymphocyte infiltration. To characterize the tumor-infiltrating lymphocytes (TILs), we isolated and cultured such cells from a surgically resected EBV-associated gastric carcinoma. They were found to be positive for CD3, CD8, T-cell receptor beta chain, and cytotoxic molecules. The isolated TILs consisted of human leukocyte antigen (HLA) class I-restricted CD8(+) cytotoxic T lymphocytes (CTLs), which killed autologous EBV-transformed cells (but not phytohemagglutinin blast cells) and recognized HLA-A24 as restriction molecules. However, the TILs did not recognize known EBV antigenic peptides presented by HLA-A24 molecules, nor HLA-A24(+) fibroblasts infected with vaccinia recombinant virus expressing each of the EBV latent proteins. EBV(+) gastric carcinomas do not express conventional target proteins of EBV-specific CTLs, and the data suggest that some cellular proteins may be involved in the strong T-cell response to EBV-associated gastric carcinoma. In addition, our data suggest that class I-restricted, antigen-specific CD8(+) CTLs are specifically expanded within EBV(+) gastric carcinoma tissue.

摘要

携带爱泼斯坦-巴尔病毒(EBV)的胃腺癌已知伴有大量淋巴细胞浸润。为了表征肿瘤浸润淋巴细胞(TILs),我们从手术切除的EBV相关胃癌中分离并培养了这些细胞。发现它们对CD3、CD8、T细胞受体β链和细胞毒性分子呈阳性。分离出的TILs由人类白细胞抗原(HLA)I类限制性CD8(+)细胞毒性T淋巴细胞(CTLs)组成,这些细胞杀死自体EBV转化细胞(但不杀死植物血凝素母细胞),并将HLA-A24识别为限制性分子。然而,TILs不识别由HLA-A24分子呈递的已知EBV抗原肽,也不识别感染了表达每种EBV潜伏蛋白的痘苗重组病毒的HLA-A24(+)成纤维细胞。EBV(+)胃癌不表达EBV特异性CTLs的传统靶蛋白,数据表明某些细胞蛋白可能参与了对EBV相关胃癌的强烈T细胞反应。此外,我们的数据表明I类限制性、抗原特异性CD8(+)CTLs在EBV(+)胃癌组织中特异性扩增。

相似文献

引用本文的文献

4
EBV-associated diseases: Current therapeutics and emerging technologies.EBV 相关疾病:当前的治疗方法和新兴技术。
Front Immunol. 2022 Oct 27;13:1059133. doi: 10.3389/fimmu.2022.1059133. eCollection 2022.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验